Stay updated on Ibrutinib Combo in Recurrent HNSCC Clinical Trial
Sign up to get notified when there's something new on the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page.

Latest updates to the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.5.2 replaces the previous v3.5.0.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedAdded Revision: v3.5.0; Deleted Revision: v3.4.3.SummaryDifference0.1%

- Check37 days agoChange DetectedStatus indicators were updated to show 'Results Submitted' and 'Revision: v3.4.3'. The previous 'No Results Posted' and 'Revision: v3.4.2' indicators were removed.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded Revision: v3.4.2. Removed the previous operating-status notice (Revision: v3.4.1) from the page.SummaryDifference0.4%

- Check73 days agoChange DetectedA site-wide notice about government funding and a version update from v3.4.0 to v3.4.1 appear on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check80 days agoChange DetectedShow glossary is now enabled on the page, and the label for the updated QC metric has been changed to 'Last Update Submitted that Met QC Criteria'. The footer now includes 'No FEAR Act Data' and the page revision shows 'Revision: v3.4.0'.SummaryDifference0.2%

Stay in the know with updates to Ibrutinib Combo in Recurrent HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page.